ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

AACI Leaders Regret “Unfortunate Rhetoric,” Pledge Support To Broder

August 11, 1989

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

In Brief: Hammer Hears A Claim for The $1 Million Wynder’s Theory On Japan’s Colon Cancer Rates: Hamburgers

March 19, 1982

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

Nurse Oncology Society Growing, developing Care Guidelines

August 19, 1977

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010